July 19, 2002
During the study, Kovacs and his team used magnetic resonance imaging (MRI) to scan the bones of 339 adults with HIV who had no symptoms of osteonecrosis, as well as of 118 HIV-negative volunteers. Researchers found that 15 -- slightly more than 4 percent -- of the asymptomatic patients with HIV had evidence of osteonecrosis in their hipbones.
More and more doctors are now diagnosing osteonecrosis in HIV patients, Kovacs and colleagues noted. The Food and Drug Administration has been receiving a growing number of notifications of new cases of osteonecrosis in the HIV-positive population. Exactly how many people in the general US population develop osteonecrosis is not known. According to recent estimates, between 10,000 and 20,000 new US cases are diagnosed each year.
Kovacs said that certain factors appeared to be associated with the development of osteonecrosis in HIV patients. For example, the condition seemed to appear more frequently in patients who took steroids, testosterone or blood fat-lowering drugs to treat the side effects of protease inhibitors. Kovacs stressed that these drugs may not, in fact, have induced the condition. "Whether these [drugs] are causal or not, we can't say," he said.
Osteonecrosis was first diagnosed in HIV-positive patients in 1990 -- before the appearance of protease inhibitors -- but more cases are being reported now that the drugs have become more common, Kovacs noted. However, since these drugs became available people are also living much longer with HIV, which could also explain the increase in osteonecrosis. Osteonecrosis "may somehow be related to HIV infection itself," Kovacs speculated.
07.16.02; Alison McCook
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.